Dr. Narendra Kumar Reddy Kanamathareddy, MD

Dr. Kanamathareddy practices at Atrium Health University City in Charlotte, North Carolina, part of Advocate Health.

Dr. Kanamathareddy's NPI, 1316355407, was assigned on August 1, 2014. Dr. Kanamathareddy holds North Carolina license 2022-03160.

Dr. Kanamathareddy's primary practice is Atrium Health University City, at 8800 North Tyron Street, Charlotte, NC 28262 in Mecklenburg County. The practice phone is (704) 548-6000.

Dr. Kanamathareddy's primary practice is Atrium Health University City in Charlotte, North Carolina, part of Advocate Health. Dr. Kanamathareddy is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Kanamathareddy to 3 more hospitals and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanamathareddy practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kanamathareddy's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Kanamathareddy is licensed in North Carolina.

CMS data shows 583 Medicare services from Dr. Kanamathareddy across 6 procedure codes in 2024, for 225 Medicare patients. Medicare paid $46,361 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Dr. Kanamathareddy in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanamathareddy's median patient age at 72, with 56% women.

In 2024, Dr. Kanamathareddy wrote 292 Medicare Part D claims for 116 patients. 88% of them were for generic drugs. CMS names the drug for 71 of them, across 5 drugs with 11 or more claims each, at $12,425 in total drug cost. In 2023, CMS named 88 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kanamathareddy for performance year 2024, reported through an alternative payment model (APM). Dr. Kanamathareddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to Dr. Kanamathareddy from 11 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $364.